Quarterly report · Q3
3151.TEDINET S100Q4CC
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥443.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥577.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥439.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥4.3bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.2bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥4.1bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.1bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥336.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥313.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥346.9bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥233.6bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥213.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥102.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥100.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥101.3bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥35.2bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥46.59 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.22 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.84 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.25 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 30.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.9% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥4.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥236m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥9.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥9.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | ¥126m |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥426.2bn |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥418.3bn |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6m |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥77m |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥276m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥448.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥440.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥453.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥443.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥4.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥119m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥8.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥8.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | ¥36m |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥421.5bn |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥414.9bn |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥6.6bn |
| jpcrp040300-q3r_E22440-000Medical Products Wholesalereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.7bn |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥1m |
| jpcrp040300-q3r_E22440-000Pharmacy Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥162m |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥7.8bn |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥0 |
| jpcrp040300-q3r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥318m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥443.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥436.5bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥6.6bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥447.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥439.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥8.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥2.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 374
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 9321700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1523 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 9321700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 9321700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1523 | |
| Cash and deposits | Prior1YearInstant | 26971000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 35219000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 119533000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 132150000000 | JPY |
| Inventories | Prior1YearInstant | 31788000000 | JPY |
| Inventories | CurrentQuarterInstant | 35205000000 | JPY |
| Accounts receivable other | Prior1YearInstant | 16617000000 | JPY |
| Accounts receivable other | CurrentQuarterInstant | 16821000000 | JPY |
| Other ca | Prior1YearInstant | 3672000000 | JPY |
| Other ca | CurrentQuarterInstant | 3149000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -50000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -50000000 | JPY |
| Current assets | Prior1YearInstant | 198532000000 | JPY |
| Current assets | CurrentQuarterInstant | 222495000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 19303000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 20678000000 | JPY |
| Land | Prior1YearInstant | 20735000000 | JPY |
| Land | CurrentQuarterInstant | 20655000000 | JPY |
| Other net ppe | Prior1YearInstant | 5722000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 4216000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 45761000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 45550000000 | JPY |
| Goodwill | Prior1YearInstant | 2874000000 | JPY |
| Goodwill | CurrentQuarterInstant | 2617000000 | JPY |
| Other ia | Prior1YearInstant | 2162000000 | JPY |
| Other ia | CurrentQuarterInstant | 2134000000 | JPY |
| Intangible assets | Prior1YearInstant | 5036000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 4751000000 | JPY |
| Investment securities | Prior1YearInstant | 47508000000 | JPY |
| Investment securities | CurrentQuarterInstant | 51191000000 | JPY |
| Other ioa | Prior1YearInstant | 16771000000 | JPY |
| Other ioa | CurrentQuarterInstant | 13520000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -576000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -1452000000 | JPY |
| Investments and other assets | Prior1YearInstant | 63703000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 63259000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 114501000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 113562000000 | JPY |
| Assets | Prior1YearInstant | 313033000000 | JPY |
| Assets | CurrentQuarterInstant | 336058000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 176685000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 201769000000 | JPY |
| Short term loans payable | Prior1YearInstant | 990000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 990000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |